英国 美国 香港 日本 瑞士
贵金属投资品牌
你当前所在页面: 大田环球首页 > 新闻资讯 > 财经新闻 > 辉瑞制药就Protonix专利侵权获得赔偿

辉瑞制药就Protonix专利侵权获得赔偿

辉瑞制药有限公司和武田药品工业已经与Teva Pharmaceutical Industries Ltd.和Sun Pharmaceutical Industries Ltd. 达成和解协议;后两家公司因为在美国推出Protonix仿制药将支付21.5亿美元的专利侵权损害赔偿。


本文来源: 大田环球贵金属

猜你喜欢:菜鸟不用愁!5分钟动画让您认识黄金投资!!

贵金属投资网

Risk Warning

Trading bullion and financial instruments carries significant risks and may not be suitable for all investors, requiring careful consideration of investment objectives, experience, and risk tolerance. Key risks include market volatility, leverage risks that can amplify gains or losses, liquidity issues that may prevent executing trades at desired prices, and technical failures in online trading systems. Prices fluctuate unpredictably, and past performance does not guarantee future results. CIDT Global Bullion Limited provides general market commentary but does not offer investment advice and is not liable for any losses incurred from reliance on its information, which may change without notice.


Jurisdiction Disclaimer

CIDT Global Bullion Limited's services are subject to local regulations and may not be available in all jurisdictions. Users are responsible for ensuring compliance with their local laws. Services are not provided in regions where they are prohibited by law, under international sanctions, or require licensing that the company does not hold. By using the platform, users confirm they are not in a restricted jurisdiction and accept full responsibility for legal compliance. The company reserves the right to decline or terminate services in restricted areas without prior notice.

QQ客服 在线客服 微信客服